p16-ARC Antibodies

Santa Cruz Biotechnology delivers a wide array of p16-ARC monoclonal antibodies for research in cell cycle regulation and tumor suppression. p16-ARC monoclonal antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). p16-ARC functions as a crucial regulator in the cell cycle by inhibiting cyclin-dependent kinases, which prevents uncontrolled cell proliferation. Research has shown that alterations in p16-ARC expression are frequently associated with various malignancies, making p16-ARC an important target for therapeutic interventions. Understanding p16-ARC function and regulation provides valuable insights into the mechanisms of tumorigenesis. Investigating p16-ARC expression patterns helps researchers identify potential biomarkers for early cancer detection. Studying p16-ARC interactions with other cell cycle regulators advances our knowledge of cellular control mechanisms. Examining p16-ARC's role in different cancer types contributes to developing targeted therapies. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of cancer biology and cell cycle regulation.